J. Derycke et al., MITOTIC BLOCK AND DELAYED LETHALITY IN HELA EPITHELIAL-CELLS EXPOSED TO ESCHERICHIA-COLI BM2-1 PRODUCING CYTOTOXIC NECROTIZING FACTOR TYPE-1, Infection and immunity, 64(5), 1996, pp. 1694-1705
The cytopathic effect (CPE) of Escherichia coli producing cytotoxic ne
crotizing factor type 1 (CNF1) was investigated by using a human epith
elial cell (HeLa) model of infection with CNF1-producing E. coli BM2-1
. This strain was shown to bind loosely, but massively, to HeLa cells.
A 4-h interaction between bacteria and eukaryotic cells triggered the
delayed appearance of a progressive dose-dependent CPE characterized
by (i) intense swelling of cells accompanied by the formation of a den
se network of actin stress fibers, (ii) inhibition of cell division du
e to a complete block in the G(2) phase of the cell cycle, and (iii) n
ucleus swelling and chromatin fragmentation. These alterations resulte
d in cell death starting about 5 days after interaction. The absence o
f multinucleation clearly distinguished the CPE from the effect produc
ed by free CNF1, which was shown to result in a true endomitosis. More
over, the CPE was neither produced by cell-free culture supernatants o
f infected cells nor prevented by a CNF1-neutralizing antiserum. Patho
genicity was completely abolished after Tn5::phoA insertion mutagenesi
s in the cnf-1 structural gene but not restored by trans complementati
on with a recombinant plasmid containing intact cnf-1 and its promoter
, These results suggest that a gene downstream of cnf-1, essential to
the induction of the CPE, was affected by the mutation. On the other h
and, transformation of the wild-type strain BM2-1,vith the same recomb
inant plasmid leads to a significant increase in both CNF1 activity an
d CPE, demonstrating the direct contribution of CNF1 to the CPE. In co
nclusion, the pathogenicity of E. coli BM2-1 for HeLa cells results fr
om a complex interaction involving cnf-1 and associated genes and poss
ibly requiring a preliminary step of binding of bacterial organisms to
target cells.